OraSure Technologies to Participate at the UBS Global Life Sciences Conference
15 9월 2010 - 12:16AM
OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that
Douglas A. Michels, President and Chief Executive Officer, will
speak to the investment community at the UBS Global Life Sciences
Conference in New York City at approximately 4:00pm Eastern Time,
(1:00pm Pacific Time) on Monday, September 20, 2010. The conference
will be simultaneously webcast over the Internet.
Interested investors can access the live audio webcast of the
discussion by going to OraSure Technologies' web site,
www.orasure.com, and clicking on the Investor Information link. A
replay of the audio webcast will be available until September 27,
2010, on OraSure Technologies' web site.
About OraSure Technologies
OraSure Technologies develops, manufactures and markets oral
fluid specimen collection devices using proprietary oral fluid
technologies, diagnostic products including immunoassays and other
in vitro diagnostic tests, and other medical devices. These
products are sold in the United States as well as internationally
to various clinical laboratories, hospitals, clinics,
community-based organizations and other public health
organizations, distributors, government agencies, physicians'
offices, and commercial and industrial entities.
For more information on the Company, please go to
www.orasure.com.
The OraSure Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=6440
CONTACT: OraSure Technologies, Inc.
Ronald H. Spair, Chief Financial Officer
610-882-1820
Investorinfo@orasure.com
www.orasure.com
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
OraSure Technologies (NASDAQ:OSUR)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024